Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Am J Health Syst Pharm ; 79(19): 1674-1684, 2022 09 22.
Article in English | MEDLINE | ID: mdl-35773088

ABSTRACT

PURPOSE: A study was conducted to identify significant associations between affective domain (AD) features identified using the Birkman Method assessment and students' likelihood to pursue and to successfully match for postgraduate residency training (PGRT), while controlling for demographic and academic variables known to impact PGRT match rates. METHODS: A retrospective analysis of 3 graduating classes of PharmD students from 2 colleges of pharmacy was performed. Data points such as PGRT match results, PGRT pursuit, student demographics, academic performance information, and AD data from the Birkman assessment were analyzed. Regression analysis was used to identify statistically significant associations between demographic, academic performance, and AD variables with both pursuit of PGRT and successful matching for PGRT. RESULTS: Data from 503 students were evaluated, with 211 (42%) pursuing PGRT. A variety of AD variables were significantly associated with pursuing PGRT and matching for PGRT. Two groups of actionable variables emerged: (1) variables associated with a lesser likelihood of pursuing PGRT but a greater likelihood of successful matching, and (2) variables associated with a greater likelihood of pursuing PGRT and a lesser likelihood of successful matching. CONCLUSION: Early identification of students' AD features along with specific interventions to promote PGRT pursuit in those less likely to pursue but more likely to match, as well as interventions to promote successful matching in students most likely to pursue but less likely to match for PGRT, is a strategy for possibly optimizing PharmD student career path planning and PGRT match success that merits further evaluation.


Subject(s)
Education, Pharmacy, Graduate , Education, Pharmacy , Pharmacy Residencies , Students, Pharmacy , Humans , Pharmacy Residencies/methods , Retrospective Studies , Students, Pharmacy/psychology
2.
Am J Pharm Educ ; 83(7): 6920, 2019 09.
Article in English | MEDLINE | ID: mdl-31619816

ABSTRACT

Objective. To conduct and evaluate the outcomes of a pharmacy faculty and preceptor development program to foster self-awareness and self-confidence. Methods. A faculty and preceptor development intervention was implemented in a multi-campus college of pharmacy to promote and assess for improvements in self-awareness and self-confidence. Faculty members and preceptors were surveyed regarding their self-perceptions and confidence at baseline and following an intervention in which they completed the Birkman Method self-assessment and participated in a training program with an active-learning component. A longitudinal follow-up survey was conducted to assess the long-term impacts of the intervention. Results. Faculty members and preceptors experienced significant improvements in self-awareness from baseline following the development intervention. They also experienced increases in self-confidence related to coaching. A survey evaluating the longitudinal impact of the intervention indicated a positive association between receiving a sufficient level of Birkman Method training and improved ability of both faculty members and preceptors to manage professional relationships. Similarly, a positive association was identified between the sufficiency of training and preceptors' confidence in their ability to manage personal relationships and stress following the intervention. Conclusion. Faculty members and preceptors teach students to be more self-aware and confident, yet both groups often need to grow in these areas themselves. A faculty and preceptor development intervention using the Birkman Method self-assessment is one approach to facilitating growth in these educators' self-awareness and self-confidence.


Subject(s)
Education, Pharmacy/methods , Faculty, Pharmacy/psychology , Preceptorship/methods , Self Concept , Adult , Female , Humans , Male , Problem-Based Learning , Program Development , Self-Assessment , Students, Pharmacy/psychology , Surveys and Questionnaires
3.
Am J Pharm Educ ; 83(4): 6865, 2019 05.
Article in English | MEDLINE | ID: mdl-31223157

ABSTRACT

Since 2004, concerns and calls for greater quality assurance in experiential education have been published. The Accreditation Council for Pharmacy Education (ACPE) "Standards 2016" provide limited differentiation across the four required practice experiences, and, as such, schools interpret them differently. Both schools and accreditation site visit teams would benefit from a common set of guidance for the required Advanced Pharmacy Practice Experiences (APPEs), so that they can ensure consistency and quality in student experiences across practice sites. To address this need for greater standardization, a taskforce of the American Association of Colleges of Pharmacy (AACP) Experiential Education (EE) Section conducted a peer-reviewed, consensus-building process, including experiential faculty and staff across multiple colleges and schools of pharmacy, to determine a common set of elements that could be used to bring consistency to the experiences and expectations for student learning in practice. Over a two year period, the taskforce reviewed the relevant literature and then drafted and revised the elements through an iterative process which allowed for established EE consortia and members of the EE section to review the draft and provide input for revision. The resulting essential elements presented here can be used to guide faculty and staff within experiential education programs in their quality assurance processes in ensuring students receive consistent experience as part of their education prior to graduation.


Subject(s)
Education, Pharmacy/standards , Faculty, Pharmacy/organization & administration , Schools, Pharmacy/standards , Students, Pharmacy , Accreditation , Humans , Problem-Based Learning
4.
Am J Pharm Educ ; 82(7): 7159, 2018 09.
Article in English | MEDLINE | ID: mdl-30323401

ABSTRACT

The 2017-2018 American Association of Colleges of Pharmacy (AACP) Student Affairs Standing Committee addressed charges related to student wellness and resilience and identified ways where AACP can assist member organizations to build positive wellbeing in students. The Committee report provides nine recommendations to AACP, three suggestions for colleges and schools of pharmacy, and one proposed policy statement related to student wellness and resilience. The report focuses on themes of consequences of burnout and declining resilience, culture shift around wellness, creating community around times of grief, partnerships with member organizations to create campus cultures that promote overall wellbeing and strategies to help students to manage stress in healthy ways. Committee members challenge AACP, and other professional organizations, to include the student voice when future programs and strategies are developed. Finally, this report provides future recommendations for the Student Affairs Standing Committee.


Subject(s)
Education, Pharmacy/methods , Advisory Committees , Annual Reports as Topic , Burnout, Professional/psychology , Humans , Schools, Pharmacy , Societies , Societies, Pharmaceutical , Students, Pharmacy/psychology , United States
7.
Am Surg ; 76(5): 492-6, 2010 May.
Article in English | MEDLINE | ID: mdl-20506878

ABSTRACT

Chronic alcohol consumption has been linked to increased morbidity and mortality in the intensive care unit setting. The purpose of our study was to assess outcomes in trauma patients admitted to our institutional university-affiliated, Level I emergency trauma unit (ETU) with and without per cent carbohydrate-deficient transferrin (%CDT) elevations over a 12-week timeframe. Markers for alcohol consumption including %CDT, gamma glutamyl transferase, and serum osmolality were measured along with the standard trauma laboratory panel on arrival to the ETU. Intensive care unit length of stay (LOS), length of time requiring ventilator support, hospital LOS, total hospital charges as well as incidences of postoperative complications were collected on all patients with a LOS greater than or equal to 48 hours. Demographics between the groups were similar. Drinking histories were more significant in the elevated %CDT group (P = 0.0006). Patients with elevated %CDT had significantly longer ICU and hospital LOS (5.1 vs. 3.9, P = 0.01; 8.7 vs. 7.1 days, P = 0.0052) and ventilator days (2 vs. 1.5 days, P = 0.0286). Complications and hospital charges were similar between groups. Trauma patients presenting to the ETU with %CDT elevations appear to be at risk for longer ICU and hospital LOS.


Subject(s)
Alcoholism/blood , Emergency Service, Hospital , Transferrin/analogs & derivatives , Wounds and Injuries/blood , Wounds and Injuries/therapy , Adolescent , Adult , Alcoholism/complications , Alcoholism/diagnosis , Biomarkers/blood , Child , Cohort Studies , Critical Care , Female , Hospitalization , Humans , Male , Middle Aged , Pilot Projects , Predictive Value of Tests , Retrospective Studies , Transferrin/metabolism , Treatment Outcome , Wounds and Injuries/etiology , Young Adult
8.
J Trauma ; 68(2): 382-6, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19935109

ABSTRACT

BACKGROUND: Evidence-based guidelines for managing nosocomial pneumonia were published in 2005. Subsequently, our surgical critical care service developed and implemented an adaptation of this guideline for use in our surgical trauma intensive care unit (STICU). This study examined outcomes for two STICU cohorts treated for pneumonia before and after guideline implementation. METHODS: A total of 130 charts were evaluated. The guideline cohort (GC) consisted of 65 patients with pneumonia managed by the surgical critical care service. These patients were prospectively identified for inclusion if they met specified clinical criteria for pneumonia diagnosis. The historical control cohort was identified retrospectively using ICD-9 coding. The primary outcome measure was ICU length of stay (LOS). Secondary outcome measures included overall LOS, mechanical ventilation days, mortality, and total cost of admission. The study was designed to have 80% power to detect a 1-day decrease in mean ICU LOS in a multivariable regression analysis. Descriptive differences were compared using two-sample t tests for continuous variables and chi for categorical variables. RESULTS: Baseline characteristics were not significantly different between cohorts. The multivariable regression analysis indicated a mean decrease of 4.6 days, 9.5 days, and 3.9 days for ICU LOS, overall LOS, and mechanical ventilation days, respectively, in the GC, with an expected mean cost reduction per admission of $23,322 (all significant at p

Subject(s)
Pneumonia, Ventilator-Associated/therapy , Practice Guidelines as Topic , Wounds and Injuries/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Cost of Illness , Female , Humans , Intensive Care Units , Length of Stay , Male , Middle Aged , Pneumonia, Ventilator-Associated/drug therapy , Pneumonia, Ventilator-Associated/economics , Regression Analysis , Retrospective Studies , Treatment Outcome , Young Adult
10.
Pharmacotherapy ; 25(8): 1073-83, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16207098

ABSTRACT

STUDY OBJECTIVE: To standardize treatment of alcohol withdrawal syndrome (AWS) in internal medicine patients using an adult AWS practice guideline with a symptom-triggered management approach. DESIGN: Prospective interventional (pilot group) and retrospective (control group). SETTING: University teaching hospital. PATIENTS: Thirty-two internal medicine patients identified as being at risk for AWS and treated according to the AWS practice guideline who were compared with 49 internal medicine patients managed with nonstandardized approaches. INTERVENTION: Patients in the pilot group were assessed using the AWS type indicator. They received lorazepam, clonidine, or haloperidol, based on AWS type indicator assessment and adult AWS practice guideline criteria. MEASUREMENTS AND MAIN RESULTS: Data collected and analyzed were drugs administered to control AWS symptoms, use of sitters and physical restraints, length of hospital stay, and discharge from hospital receiving tapered drug therapy. Pilot patients received 46.6% less benzodiazepine (p=0.001), 20% more clonidine (p=0.01), and 18.2% more haloperidol (p=0.002) than control patients. No drug therapy was required in 19% of pilot patients compared with 2% of controls (p=0.01). Significantly more control (71.4%) than pilot patients (18.8%) were discharged with tapered benzodiazepine therapy (p

Subject(s)
Alcohol Withdrawal Delirium , Adult , Aged , Female , Humans , Male , Middle Aged , Adrenergic alpha-Agonists/therapeutic use , Alcohol Withdrawal Delirium/drug therapy , Alcohol Withdrawal Delirium/psychology , Alcohol Withdrawal Delirium/therapy , Anti-Anxiety Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Clonidine/therapeutic use , Haloperidol/therapeutic use , Hospitals, Teaching , Internal Medicine , Length of Stay , Lorazepam/therapeutic use , Pilot Projects , Restraint, Physical , Retrospective Studies , Treatment Outcome , Practice Guidelines as Topic
11.
Pharmacotherapy ; 23(7): 843-54, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12885097

ABSTRACT

STUDY OBJECTIVE: To standardize treatment of alcohol withdrawal syndrome (AWS) in surgical patients using an AWS practice guideline with a symptom-triggered approach. DESIGN: Prospective interventional (pilot group) and retrospective (comparison group). SETTING: University teaching hospital. PATIENTS: Thirty-eight trauma, orthopedic, and general surgery patients identified at risk for AWS in the pilot group, and 34 patients who were managed using nonstandardized approaches. INTERVENTIONS: At-risk patients in the pilot group were assessed using the AWS Type Indicator. They received lorazepam, clonidine, or haloperidol, based on AWS Type Indicator assessment and AWS practice guideline criteria. MEASUREMENTS AND MAIN RESULTS: A standardized symptom-triggered approach to managing AWS was expected to decrease the use of benzodiazepines, avoid undertreatment of adrenergic hyperactivity and delirium, decrease the need for sitters and physical restraints, and reduce hospital length of stay. Pilot patients received a mean of 23 mg less benzodiazepine (p=0.01), 0.1 mg more clonidine (p=0.01), and 20 mg less haloperidol (p=0.06) than comparison patients. Pilot patients also required significantly fewer sitter hours (p=0.04) and hours of restraint use (p=0.09) than comparison patients. No significant differences were found between groups for length of stay (p=0.77). CONCLUSIONS: This pilot project suggests that trauma, orthopedic, and general surgery patients at risk for AWS can be safely and effectively managed with a standardized, symptom-triggered approach. Moreover, this approach decreased the amounts of benzodiazepines and haloperidol administered to patients at risk for AWS.


Subject(s)
Ethanol/adverse effects , Substance Withdrawal Syndrome/drug therapy , Surgical Procedures, Operative , Adolescent , Adult , Aged , Alcohol-Related Disorders/complications , Clonidine/administration & dosage , Clonidine/therapeutic use , Female , Haloperidol/administration & dosage , Haloperidol/therapeutic use , Humans , Length of Stay , Lorazepam/administration & dosage , Lorazepam/therapeutic use , Male , Middle Aged , Pilot Projects , Postoperative Complications/prevention & control , Practice Guidelines as Topic , Prospective Studies , Restraint, Physical , Retrospective Studies , Severity of Illness Index , Substance Withdrawal Syndrome/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...